Navigation Links
Erika Schwartz MD Congratulates Oprah Winfrey for Spotlighting Bioidentical Hormones
Date:1/15/2009

For now, she says: "Let's just celebrate the fact that bioidentical hormones are coming out and are finally being considered as viable treatments for feeling lousy. No longer are we hearing that bioidenticals are just a marketing term. Now that is progress!

New York, NY (PRWEB) January 15, 2009 -- Today is a big day for women's health and bioidentical hormones, says Erika Schwartz MD in her latest blog at www.derika.com.

For the first time, she says, mainstream media is acknowledging that women are suffering unnecessarily and that hormone imbalance is an overwhelming handicap that needs attention and legitimate treatments. It can no longer be swept under the rug.

Dr. Erika notes it took someone like Oprah Winfrey, who is suffering from inadequately treated thyroid problems, menopausal hormone loss and its attendant weight gain to blast the hinges off the door to bioidentical hormone therapy.

Acknowledgement is always the precursor to enlightenment, she adds.

Dr. Erika says she hopes Oprah will consider bioidenticals an important ingredient in her commitment to achieving true wellness.

For now, she says: "Let's just celebrate the fact that bioidentical hormones are coming out and are finally being considered as viable treatments for feeling lousy. No longer are we hearing that bioidenticals are just a marketing term. Now that is progress!

"The next step involves educating the medical community about the existence of bioidenticals, providing them with the studies about them, teaching them the difference between how bioidenticals and non-identical hormone molecules work in the human body and making sure they know that bioidenticals are FDA approved and available at your local drugstore."

Dr. Erika says doctors also need to understand the role and usefulness of compounding pharmacies and get involved with who compounds the hormones they prescribe.

Finally, Dr. Erika says, balanced and honest studies must be undertaken on a large scale and in full view that compare the efficacy and safety of bioidenticals to their non-identical counterparts. The era of creating confusion and muddying the waters of hormone therapies has reached its end.

DrErika.com is dedicated to providing an independent, honest view on healthcare topics and issues from a position of devoted patient advocacy.

Its founder, Erika Schwartz MD, is an internationally-recognized patient advocate, practicing physician, expert in conventional and integrative medicine, author of four books and a frequent guest on TV and radio. DrErika.com doesn't tailor its stories to suit sponsors - it does not accept sponsors.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1872574.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation
2. Steve and Paula Mae Schwartz Honored With Publicity Club of New Englands Crystal Bell Award
3. SAND Technology Appoints Zainab Ahmed Schwartz as CFO
4. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
5. Anapol Schwartz Attorney Named to Executive Committee of American Association for Justice
6. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
7. American Heart Association Congratulates Pioneer Heart Surgeon for Being Named Recipient of Congressional Gold Medal Award
8. Mission Pharmacal Congratulates Exemplary Womens Health Researchers
9. Internet2 Congratulates FCC Rural Health Care Pilot Program Grant Awardees
10. SNM congratulates NOPR and its supporting organizations on successful conclusion of project
11. Coalition for 21st Century Medicine Congratulates U.S. Senate on Passage of Genetic Information Nondiscrimination Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University College ... academic programs. , Answering to the increasing demand for curricular specializations, the Certificate ... and environmental and land use law. ,  , “The demand for lawyers with ...
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For ... their lives in military battle for the country. The nonprofit Hope For Heroes ... more programs that empower independence for disabled military veterans, as well as police, firemen, ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... one that has a significant negative impact on long-term patient survival, reports a ... The results, published online this week in the Journal of Thoracic and Cardiovascular ...
(Date:5/26/2016)... ... 2016 , ... MadgeTech will be showcasing its line of data logging ... at the MadgeTech headquarters. With products sold in more than 100 countries around the ... NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... WELLESLEY, Massachusetts , May 26, 2016 ... sequencing (NGS) has matured into an essential life science ... research and development applications. BCC Research reveals in its ... of a second growth phase, one powered by a ... applied fields.      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ...
(Date:5/25/2016)... May 25, 2016 According to ... Type (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic ... User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to ... Medical Animation Market for the forecast period of 2016 ... 301.3 Million by 2021 from USD 117.3 Million in ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, ... QGEN ; Frankfurt Prime Standard: QIA) today announced that the ... Therawis Diagnostics GmbH to develop and commercialize predictive assays in ... PITX2 as a marker to predict effectiveness of anthracycline treatment ... "We are pleased to partner with Therawis, which developed ...
Breaking Medicine Technology: